Alyeska Investment Group L.P. Invests $2.49 Million in Kestra Medical Technologies, Ltd. $KMTS

Key Points

• Alyeska Investment Group L.P. has acquired 100,000 shares in Kestra Medical Technologies, valued at approximately $2,492,000, representing about 0.19% of the company.
• Kestra Medical Technologies' stock is currently valued at $17.00, with a 52-week range between $13.25 and $26.15.
• Wells Fargo downgraded their price objective for Kestra Medical from $28.00 to $27.00, while the stock retains a consensus rating of "Moderate Buy."

Alyeska Investment Group L.P. purchased a new stake in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 100,000 shares of the company's stock, valued at approximately $2,492,000. Alyeska Investment Group L.P. owned approximately 0.19% of Kestra Medical Technologies as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Quarry LP purchased a new position in Kestra Medical Technologies during the first quarter worth about $33,000. Virtu Financial LLC bought a new stake in shares of Kestra Medical Technologies during the 1st quarter valued at about $210,000. Armistice Capital LLC purchased a new position in shares of Kestra Medical Technologies during the first quarter worth about $312,000. Russell Investments Group Ltd. bought a new position in shares of Kestra Medical Technologies in the first quarter worth approximately $457,000. Finally, Caas Capital Management LP purchased a new stake in Kestra Medical Technologies in the first quarter valued at approximately $1,470,000.

Kestra Medical Technologies Stock Performance

NASDAQ KMTS traded up $0.21 during trading on Thursday, hitting $18.40. 461,368 shares of the company's stock traded hands, compared to its average volume of 208,865. The business's fifty day moving average price is $16.33. Kestra Medical Technologies, Ltd. has a 12-month low of $13.25 and a 12-month high of $26.15. The company has a quick ratio of 6.72, a current ratio of 6.72 and a debt-to-equity ratio of 0.20.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company cut their target price on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a research report on Thursday, July 17th. Five research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat, Kestra Medical Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $27.33.

Kestra Medical Technologies Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.